FLUARIX TETRA SUSPENSION FOR INJECTION
Product details
Registration number: SIN14760P
Classification: Prescription Only
Active ingredients:
- Influenza Virus (SH) A/Missouri/11/2025 (H1N1)pdm09-like strain
- Influenza Virus (SH) A/Singapore/GP20238/2024 (H3N2)-like strain
- Influenza Virus (SH) B/Austria/1359417/2021 - like strain
- Influenza Virus (SH) B/Phuket/3073/2013-like strain
Strength:
- 15mcg HA/0.5ml
- 15mcg HA/0.5ml
- 15mcg HA/0.5ml
- 15mcg HA/0.5ml
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J07BB02
HSA approval date: 23 March 2015
Manufacturer(s):
- GlaxoSmithKline Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG
- GlaxoSmithKline Biologicals SA
- GlaxoSmithKline Biologicals (Filling)
Manufacturing country/countries: BELGIUM; FRANCE; GERMANY
What are the HSA registration number and classification for FLUARIX TETRA SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14760P
Classification: Prescription Only
What active ingredients and strength are recorded for FLUARIX TETRA SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Influenza Virus (SH) A/Missouri/11/2025 (H1N1)pdm09-like strain
- Influenza Virus (SH) A/Singapore/GP20238/2024 (H3N2)-like strain
- Influenza Virus (SH) B/Austria/1359417/2021 - like strain
- Influenza Virus (SH) B/Phuket/3073/2013-like strain
Strength:
- 15mcg HA/0.5ml
- 15mcg HA/0.5ml
- 15mcg HA/0.5ml
- 15mcg HA/0.5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for FLUARIX TETRA SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for FLUARIX TETRA SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for FLUARIX TETRA SUSPENSION FOR INJECTION?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GlaxoSmithKline Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG
- GlaxoSmithKline Biologicals SA
- GlaxoSmithKline Biologicals (Filling)
Manufacturing country/countries: BELGIUM; FRANCE; GERMANY
Where can I look up FLUARIX TETRA SUSPENSION FOR INJECTION in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14760P or the exact product name FLUARIX TETRA SUSPENSION FOR INJECTION. The general register link does not preselect this product.
What are the source dates for this FLUARIX TETRA SUSPENSION FOR INJECTION record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this FLUARIX TETRA SUSPENSION FOR INJECTION record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14760P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)